Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.
Abstract
Context: Hypoactive sexual desire disorder (HSDD) is one of the most common sexual problems reported by women, but few studies have been conducted to evaluate treatments for this condition. Objective: The objective of this study was to evaluate the efficacy and safety of a testosterone patch in surgically menopausal women with HSDD. Design: The design was a randomized, double-blind, parallel-group, placebo-controlled, 24-wk study (the Intimate SM 1 study). Setting: The study was performed at private or institutional practices. Patients: The subjects studied were women, aged 26–70 yr, with HSDD after bilateral salpingo-oophorectomy who were receiving concomitant estrogen therapy. Placebo (n = 279) or testosterone 300 μg/d (n = 283) was administered. There were 19 patients who withdrew due to adverse events in the placebo group and 24 in the 300 μg/d testosterone group. Intervention: Testosterone (300 μg/d) or placebo patches were applied twice weekly. Main Outcome Measure(s): The primary end point was the change in the frequency of total satisfying sexual activity at 24 wk. Secondary end points included other sexual functioning end points and safety assessments. Results: At 24 wk, there was an increase from baseline in the frequency of total satisfying sexual activity of 2.10 episodes/4 wk in the testosterone group, which was significantly greater than the change of 0.98 episodes/4 wk in the placebo group (P = 0.0003). The testosterone group also experienced statistically significant improvements in sexual desire and a decrease in distress. The overall safety profile was similar in both treatment groups. Conclusion: In the Intimate SM 1 study, the testosterone patch improved sexual function and decreased distress in surgically menopausal women with HSDD and was well tolerated in this trial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another androgen (testosterone) also improves sexual function in surgically menopausal women (55,56).”
From Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial (2008) · cites this paper as [56]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
Shifren, J. L., Braunstein, G. D., Simon, J. A., Casson, P. R., Buster, J. E., Redmond, G. P., Burki, R. E., Ginsburg, E. S., Rosen, R. C., Leiblum, S. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431002 · Cited by 954 · cited 1×
“01 300 g/d 271 7 [0, 14] 143 19 [9, 36] Androstenedione [50–250 ng/dl] Placebo 276 58 [32, 108] 157 52 [21, 87] 0.”
Self-citationSherwin, B. B., Gelfand, M. M., & Brender, W. (1985) · Psychosomatic Medicine · doi:10.1097/00006842-198507000-00004 · Cited by 547 · cited 1×
“5] Total testosterone [12–50 ng/dl] Placebo 279 17 [8, 28] 219 16 [7, 28] 0.”
The role of androgen in the maintenance of sexual functioning in oophorectomized women.
Sherwin, B. B., & Gelfand, M. M. (1987) · Psychosomatic Medicine · doi:10.1097/00006842-198707000-00009 · Cited by 394
Basson, R., McInnes, R., Smith, M. D., Hodgson, G., & Koppiker, N. (2002) · Journal of Women's Health & Gender-Based Medicine · doi:10.1089/152460902317586001 · Cited by 289
HORMONAL DYNAMICS ASSOCIATED WITH THE MENOPAUSE
Judd, H. L. (1976) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-197612000-00005 · Cited by 158
LORENZO, E. M. (1970) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-31-5-556 · Cited by 131
Psychological Reactions and Sexual Life after Hysterectomy with and without Oophorectomy
Nathorst-Böös, J., & von Schoultz, B. (1992) · Gynecologic and Obstetric Investigation · doi:10.1159/000292735 · Cited by 126
DEROGATIS, L., RUST, J., GOLOMBOK, S., BOUCHARD, C., NACHTIGALL, L., RODENBERG, C., KUZNICKI, J., & MCHORNEY, C. A. (2004) · Journal of Sex & Marital Therapy · doi:10.1080/00926230490247183 · Cited by 121
Self-citationSexual response after hysterectomy-oophorectomy: Recent studies and reconsideration of psychogenesis
ZUSSMAN, L., Zussman, S., Sunley, R., & Bjornson, E. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90730-4 · Cited by 103
Cited by
Items 301–400 of 472
Androgen Replacement Therapy in Androgen-Deficient Women with Hypopituitarism
Zang, H., & Davis, S. R. (2008) · Drugs · doi:10.2165/00003495-200868150-00001 · Cited by 7
“circulating free testosterone levels found in young terol levels were not decreased by the dose of testoshealthy women.[39,40] The positive effects on sexual terone used and markers of increased cardiovascular”
BackgroundSelf-citationCalculation of Bioavailable and Free Testosterone in Men: A Comparison of 5 Published Algorithms
Meikle, A. W. (2007) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70219-1 · Cited by 7
Psychological Approaches for Low Sexual Arousal
Borg, C., & de Jong, P. J. (2017) · Wiley eBooks · doi:10.1002/9781118877142.ch18 · Cited by 7
Kim, N. N., Wessells, H., DiSanto, M. E., Ferrini, M. G., Lin, G., Pfaus, J. G., Priviero, F. B. M., Yong, P. J., & Podlasek, C. A. (2025) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeaf032 · Cited by 6
Løbo, R. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00014-0 · Cited by 8
Hypoactive Sexual Desire Disorder in Premenopausal Women: Case Studies
Miner, M. M., Sadovsky, R., & Buster, J. E. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.01.2522 · Cited by 6
Diagnosis and Treatment of Hypoactive Sexual Desire Disorder
Amato, P., & Buster, J. E. (2009) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e3181bf48c9 · Cited by 6
Götte, M., Kalkhake, K., Ploeger, S., Kiesel, L., & Stute, P. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.09.007 · Cited by 6
Bitzer, J., & Kirana, P. (2020) · Springer eBooks · doi:10.1007/978-3-030-52298-8_10 · Cited by 6
Testosterone patches for female sexual dysfunction
(2009) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2009.02.0007 · Cited by 7
Garcia, J. R., Escasa-Dorne, M. J., Gray, P. B., & Gesselman, A. N. (2015) · International Journal of Sexual Health · doi:10.1080/19317611.2015.1030529 · Cited by 6
“Studies on administration of T (via patch or injection) have shown an increase in women’s sexual desire (Simon et al., 2005).”
BackgroundPharmacotherapeutic options for the treatment of menopausal symptoms
Genazzani, A. R., Monteleone, P., Giannini, A., & Simoncini, T. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1921148 · Cited by 10
Understanding Women's Sexual Health: A Case-Based Approach
Marnach, M. L., & Casey, P. M. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.12.1382 · Cited by 6
Advances in hormone replacement therapy: making the menopause manageable
Palacios, S. (2008) · BMC Women s Health · doi:10.1186/1472-6874-8-22 · Cited by 83
“In all five cases, the efficacy and safety of a patch that released 300 μg of testosterone daily were analyzed [31-35].”
BackgroundHormone replacement therapy in gynecologic cancer: oncologic safety and alternative therapies
Aznar, A. L., Elyashiv, O., Dababou, S., Palasz, N. A., Cantürk, M. M., Macias, R. M., Pavone, M., Jayraj, A. S., Hsu, H., & Ramirez, P. T. (2025) · International Journal of Gynecological Cancer · doi:10.1016/j.ijgc.2025.102809 · Cited by 9
Male hypogonadism and testosterone replacement therapy
Seal, L. (2013) · Medicine · doi:10.1016/j.mpmed.2013.07.010 · Cited by 6
Osborne, V., Layton, D., & Shakir, S. (2014) · Post Reproductive Health · doi:10.1177/2053369114535762 · Cited by 6
An exploratory study of the relationship between second toe length and androgen-linked behaviors.
Harrison, M. A. (2010) · Journal of Social Evolutionary and Cultural Psychology · doi:10.1037/h0099286 · Cited by 6
Zeng, J., Xie, T.-F., Huang, T., Li, F., Wang, Z., & Feng, L. (2022) · AAPS PharmSciTech · doi:10.1208/s12249-021-02201-9 · Cited by 5
Androgen replacement therapy in women
Lebbe, M., Hughes, D., Reisch, N., & Arlt, W. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.45 · Cited by 7
Bitzer, J., & Alder, J. (2010) · Therapeutische Umschau · doi:10.1024/0040-5930/a000021 · Cited by 7
Actualización sobre el trastorno del deseo sexual hipoactivo femenino
Cabello-Santamaría, F., & Palacios, S. (2012) · Progresos de Obstetricia y Ginecología · doi:10.1016/j.pog.2011.11.012 · Cited by 11
Botelho, M. A., de Queiróz, D. B., Carvalho, C. F., Freitas, A., Barros, G., Gouvea, J., Patrus, L., Bannet, M., do Rêgo, A. C. M., Araújo-Filho, I., et al. (2015) · Medical Express · doi:10.5935/medicalexpress.2015.05.03 · Cited by 6
Las hormonas esteroideas sexuales, el envejecimiento y el ejercicio
Becerro, J. F. M. (2008) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 7
Interactions of Sleep and Female Sexual Function: a Review
Kling, J. M., Kapoor, E., & Faubion, S. S. (2018) · Current Sexual Health Reports · doi:10.1007/s11930-018-0180-3 · Cited by 5
Løbo, R. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00015-9 · Cited by 5
Cipriani, S., Maseroli, E., & Vignozzi, L. (2021) · Springer eBooks · doi:10.1007/978-3-030-77111-9_8 · Cited by 7
Osborne, V., Hazell, L., Layton, D., & Shakir, S. (2010) · Drug Safety · doi:10.2165/11533720-000000000-00000 · Cited by 6
Pitkin, J., REES, M. C. P., Gray, S., Lumsden, M. A., Marsden, J., Stevenson, J. C., & Williamson, J. (2008) · Menopause international · doi:10.1258/mi.2008.008009 · Cited by 9
Shifren, J. L. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000194820.69150.96 · Cited by 5
“Specifically regarding trials of testosterone therapy, several large studies of transdermal testosterone for estrogen-treated, surgically menopausal women with hypoactive sexual desire disorder demonstrated the expected approximately 30% improvement in sexual activity with placebo patches.(5)”
BackgroundClinical management of androgen excess and defect in women
Rosato, E., Sciarra, F., Minnetti, M., Degjoni, A., & Venneri, M. A. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2279537 · Cited by 4
Lifestyle-Medikamente in der Medizin
Harth, W., Seikowski, K., Hermes, B., & Gieler, U. (2008) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-007-0473-z · Cited by 4
Testosterone for low libido in postmenopausal women?
Roth, M. Y., & Amory, J. K. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.4.2.131 · Cited by 4
Santoro, N., & Wierman, M. E. (2021) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000658 · Cited by 4
Hypoactive sexual desire disorder
RYMER, J. M., Wylie, K. R., Barnes, T., Mander, A. M., Buckler, H. M., & Dean, J. P. (2010) · The Obstetrician & Gynaecologist · doi:10.1576/toag.12.4.237.27615 · Cited by 4
Confronting the Challenges of Postmenopausal Urogenital Health
Farage, M. A., Miller, K. W., & Ledger, W. J. (2010) · Aging Health · doi:10.2217/ahe.10.44 · Cited by 4
Bitzer, J., & Alder, J. (2008) · Der Gynäkologe · doi:10.1007/s00129-007-2060-1 · Cited by 5
Menopause and Care of the Mature Woman
Lobo, R. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-323-06986-1.00014-7 · Cited by 7
Sexuality and intimacy after cancer
Potter, J. E., & Johnston, K. T. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1015-1.00057-6 · Cited by 5
Testosterone Therapy in Women: A Clinical Challenge.
Dunsmoor-Su, R. F., Fuller, A., & Voedisch, A. J. (2021) · PubMed · doi:10.1097/aog.0000000000004566 · Cited by 3
Viana, D. P. D. C., Câmara, L. C., & Alto, L. D. S. M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1789504 · Cited by 6
Chapitre 8 : Sexualité et ménopause
Author, N. (2019) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2019.02.147 · Cited by 3
Neuroendocrinological Aspects of a Tailored Hormonal Contraception
Battipaglia, C., Szeliga, A., Setti, V., Bala, G., Chedraui, P. A., Genazzani, A. D., & Męczekalski, B. (2025) · Endocrines · doi:10.3390/endocrines6030037 · Cited by 4
“Although androgens are widely recognized as key regulators of female sexual health, the precise threshold for androgen deficiency that results in clinically significant sexual dysfunction remains unclear [66].”
Clapauch, R., Weiss, R. V., & Rech, C. M. Z. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_17 · Cited by 5
Challenges of prescribing testosterone for sexual dysfunction in women: Number 7 – 2024
Lara, L. A. D. S., Pereira, J. M. D. L., de Paula, S. R. C., de Oliveira, F. F. L., Cunha, A. M., Lerner, T., de Carvalho, Y. M. V., Rezende, G. P., & Benetti‐Pinto, C. L. (2024) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2024fps07 · Cited by 5
Management of Hypoactive Sexual Desire Disorder (HSDD)
Krapf, J. M., Buster, J. E., & Goldstein, A. T. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3100-2_21 · Cited by 3
Use of androgens at different stages of life: climacterium
Nácul, A. P., Rezende, G. P., Yela, D. A., Maranhão, T. M. D. O., Costa, L. O. B. F., dos Reis, F. M., Maciel, G. A. R., Damásio, L. C. V. D. C., Silva, A. C. J. D. S. R. E., Lopes, V. M., et al. (2022) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0041-1740936 · Cited by 5
“(1) Thus, evidences that the female sexual function (SF) is associated with androgenic action are based, above all, on studies that observed an improvement in HSDD in postmenopausal women treated with testosterone.(2-5)”
BackgroundConsensus statement for non-estrogen-based treatments for menopausal symptoms
Woyka, J., & Tanna, N. K. (2014) · Post Reproductive Health · doi:10.1177/2053369114536103 · Cited by 3
Klinik der Perimenopause, der Postmenopause und des Seniums
Ortmann, O., & Hadji, P. (2009) · Springer eBooks · doi:10.1007/978-3-540-89760-6_20 · Cited by 4
Miller, K. K., Biller, B. M. K., Beauregard, C., Lipman, J. G., Jones, J., Schoenfeld, D., Sherman, J. C., Swearingen, B., Loeffler, J. S., & Klibanski, A. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000243908.12290.e8 · Cited by 3
Female Sexual Dysfunction and Premature Menopause with Focus on Women’s Wording
Graziottin, A., & Lukasiewicz, M. E. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3100-2_28 · Cited by 4
Testosterone Replacement Therapy in Men and Women
El‐Maouche, D., & Dobs, A. S. (2010) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-374271-1.00060-5 · Cited by 5
RETIRED: Managing Menopause Chapter 8 Sexuality and Menopause
(2014) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30464-3 · Cited by 3
RetractedHypoactive sexual desire disorder: can we treat it with drugs?
Nappi, R. E., Terreno, E., Martini, E., Albani, F., Santamaria, V., Tonani, S., & Polatti, F. (2010) · Sexual & Relationship Therapy · doi:10.1080/14681991003669030 · Cited by 6
“A series of double-blind, randomized, placebo-controlled studies examined the efficacy and safety of a transdermal T patch (300 mcg) in postmenopausal women with HSDD (Buster et al., 2005; Simon et al., 2005).”
BackgroundSustratos hormonales de la respuesta sexual femenina
Mas, M. (2007) · Revista Internacional de Andrología · doi:10.1016/s1698-031x(07)74032-3 · Cited by 4
Mathews, K., Swann, S. A., Campbell, A. R., Lee, M. M., Pang, D., Tognazzini, S., Carter, A., Loutfy, M. R., King, E. M., Nicholson, V., et al. (2025) · The Journal of Sex Research · doi:10.1080/00224499.2025.2503896 · Cited by 2
Female Sexual Interest and Arousal Disorder
McKenzie, N. (2018) · Physician Assistant Clinics · doi:10.1016/j.cpha.2018.02.007 · Cited by 3
What is the Role of Testosterone Therapy in Postmenopausal Women? A SWOT Analysis
Aktöz, F., Güneş, A. C., & Erel, C. T. (2023) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5008159 · Cited by 2
“Testosterone was reported to be effective on sexual desire and average satisfying sexual event per month in postmenopausal women [22–25].”
BackgroundTorres, L. R., Anglès‐Acedo, S., Chardi, L. L., Mensión, E., & Castelo‐Branco, C. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2364220 · Cited by 4
Davis, S. R. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.024 · Cited by 2
Self-citationSexuality and Breast Cancer Survivorship
Hahn, K. M. E. (2007) · Springer eBooks · doi:10.1007/978-0-387-34952-7_19 · Cited by 2
Somboonporn, W. (2006) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/01.gco.0000233938.36554.37 · Cited by 2
Patient scenario: A 53-year-old woman with hypoactive sexual desire disorder
Palacios, S., & Graziottin, A. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.05.002 · Cited by 2
Arlt, W. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.06.016 · Cited by 3
“…of satisfying sexual activity (SAL) and sexual desire (PFSF), decrtease in personalo distress (PDS); significant incidence of androgenic skin side effects, no serious adverse events Simon et al. 2005 [48] Women with surgical menopause (N = 447) Randomized, doubleblind, placebocontrolled,…”
SHULMAN, L. P. (2007) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/s1090-798x(08)70229-7 · Cited by 2
Störungen des sexuellen Interesses und der sexuellen Erregung bei der Frau
Hartmann, U. H. (2017) · Springer eBooks · doi:10.1007/978-3-662-54415-0_9 · Cited by 2
Testosterone supplementation and the gender divide
Donovitz, G. S. (2021) · Neurourology and Urodynamics · doi:10.1002/nau.24622 · Cited by 2
“Shortly thereafter, a testosterone patch called (Intrinsa) was also promoted for FDA approval in women.(13,14) The data on this product showed significant improvements over placebo and consequently held much promise for FDA approval.”
BackgroundPfaus, J. G. (2022) · Current Sexual Health Reports · doi:10.1007/s11930-022-00335-w · Cited by 2
“, [24]) showing far greater efficacy of Intrinsa on indices of sexual arousal, desire, and pleasure from orgasm, and a significant drop in personal distress, relative to the SSE measure.”
BackgroundTopical Testosterone Gel for the Treatment of Male Hypogonadism
Udeoji, D. U., Phan, A., Katsiyiannis, P., Willix, R., & Schwarz, E. R. (2012) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s7348 · Cited by 2
15 Seksuele disfuncties bij vrouwen
ter Kuile, M., Both, S., Bolle, G., & Weijenborg, P. T. M. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6806-8_15 · Cited by 2
Sexual Dysfunction in Men and Women with Chronic Kidney Disease
Palmer, B. F. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373870-7.00027-2 · Cited by 2
Lifestyle Drugs in Old Age – A Mini-Review
Harth, W., Seikowski, K., & Hermes, B. (2008) · Gerontology · doi:10.1159/000173697 · Cited by 2
Polikistik over sendromunda androjen seviyeleri ve seksüel disfonksiyon
Erol, R. S., & Kadıoğlu, P. (2021) · Androloji Bülteni · doi:10.24898/tandro.2021.75002 · Cited by 1
Impact of estroprogestin therapies on bone health from adolescence to postmenopause
Guabello, G., Silvia, F., Silvia, C., Ruotolo, E., Antonio, R., Jacopo, B., Bonomi, M., Giovanni, G., & Corbetta, S. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02802-2 · Cited by 2
“In double-blind, placebo-controlled clinical trials in naturally and surgically menopausal women, testosterone therapy resulted in statistically significant improvements in the number of satisfying sexual events, sexual desire, and sexual distress that were two-fold greater than placebo [105].”
Incorporating mindfulness into an internet-based intervention for female sexual dysfunctions
Hucker, A. (2013) · Cited by 1
Abordaje clínico de las disfunciones sexuales femeninas: perspectiva orgánica
Mas, M., & Báez, D. (2007) · Revista Internacional de Andrología · doi:10.1016/s1698-031x(07)74039-6 · Cited by 4
L’effet placebo : importance de la prise en charge
Porto, R. (2011) · Sexologies · doi:10.1016/j.sexol.2011.01.006 · Cited by 1
Managing short-term menopausal symptoms (Section 8)
Abernethy, K. (2016) · Post Reproductive Health · doi:10.1177/2053369116648269 · Cited by 2
The Case for Androgens in Menopausal Women: When and How?
Huang, G. T.-W., & Basaria, S. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-42451-4_10 · Cited by 1
Intravaginal DHEA for the Treatment of Vulvovaginal Atrophy, Intracrinology at Work
Labrie, F. (2018) · ISGE series · doi:10.1007/978-3-319-63540-8_24 · Cited by 1
Genitourinary and Sexual Health
Krapf, J. M., Nwabuebo, A., & Miller, L. (2021) · Springer eBooks · doi:10.1007/978-3-030-85484-3_11 · Cited by 1
LIU, J. H., & Arredondo, F. (2017) · Springer eBooks · doi:10.1007/978-3-319-52210-4_9 · Cited by 1
Dias-Amaral, A. (2019) · Mental Health & Human Resilience International Journal · doi:10.23880/mhrij-16000133
“The use of transdermal testosterone patches (in a daily dose of 300mcg) in postmenopausal women with HSDD has had positive results with benefits in desire, responsiveness, orgasm and satisfaction, with good safety profile [2-5].”
BackgroundBitzer, J., & Alder, J. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-916-1_29 · Cited by 1
Morris, E., & Burbos, N. (2010) · PubMed · Cited by 2
Sexual Disorders in Breast Cancer Survivors
SÜTCÜOĞLU, B. M. (2022) · Eurasian Journal of Medical Advances · doi:10.14744/ejma.2022.00710 · Cited by 1
“[47] 48-50] Two further trials comprising 115 people explored whether sexual function improved with venlafaxine, clonidine, or bupropion in relation to hot flashes as the main outcome.”
BackgroundSexual Health in Women with Diabetes
Salonia, A., Lanzi, R., Bosi, E., Rigatti, P., & Montorsi, F. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-250-6_8 · Cited by 1
Ahrendt, H.-J., & Friedrich, C. (2012) · Springer eBooks · doi:10.1007/978-3-642-20923-9_58 · Cited by 1
ESHRE Guideline: management of women with premature ovarian
Webber, L. J., Davies, M. C., Anderson, R. A., BARTLETT, J., Braat, D. D. M., Cartwright, B., Cífková, R., Keizer‐Schrama, S. D. M., Hogervorst, E., Janse, F., et al. (2016) · Cited by 1
The Relationship between Sexual Function and Body Mass Index among Infertile Women
Yousef, S., Mehasib, S., Ramadan, S., & Saied, A. (2017) · Egyptian Journal of Health Care · doi:10.21608/ejhc.2017.9733 · Cited by 1
“Others may not want to deal with the answers and questions that follow (Simon et al., 2010).”
BackgroundMenopausal Hormone Therapy to Prevent Chronic Conditions
Sánchez‐Borrego, R. (2019) · Springer eBooks · doi:10.1007/978-3-030-13936-0_22 · Cited by 1
Hormonal profile in postmenopausal women: do they need androgen therapy?
Zaydieva, Y. Z. (2019) · Medical alphabet · doi:10.33667/2078-5631-2019-1-1(376)-32-40 · Cited by 1
Praxishandbuch Männergesundheit: Interdisziplinärer Beratungs- und Behandlungsleitfaden
Harth, W., Brähler, E., & Schuppe, H.-C. (2012) · Medizinisch Wissenschaftliche Verlagsgesellschaft eBooks · doi:10.32745/9783954660162 · Cited by 3
Єфименко, О. О. (2020) · Reproductive Endocrinology · doi:10.18370/2309-4117.2020.51.72-88 · Cited by 2
Noss, D., & Ortmann, O. (2012) · Springer eBooks · doi:10.1007/978-3-642-20923-9_9 · Cited by 1
Androgen Therapy in Women with Testosterone Insufficiency: Looking Back and Looking Ahead
Traish, A. M., & Morgentaler, A. (2022) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2021.0030 · Cited by 5
Sexual Dysfunction in Men and Women With Chronic Kidney Disease
Palmer, B. F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803247-3.00017-9 · Cited by 1
Positive emotions and sexual desire among healthy women
Brough, E. J. (2009) · Deep Blue (University of Michigan) · Cited by 3
Menopause, Aging, and Sexual Response in Women
Brotto, L. A., & Luria, M. (2008) · Wiley eBooks · doi:10.1002/9781118269978.ch9 · Cited by 5
Reis, S. L. B. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2013.tde-08112013-105531 · Cited by 2
Metadata
- Authors
- Simon, J., Braunstein, G., Nachtigall, L., Utian, W., Katz, M., Miller, S., Waldbaum, A., Bouchard, C., Derzko, C., Buch, A., Rodenberg, C., Lucas, J., & Davis, S.
- Affiliations
- Women’s Health Research Center (J.S.), Laurel, Maryland 20707;
- Cedars-Sinai Medical Center (US)
- New York University (US)
- Rapid Medical Research (US)
- Katz, Kade, and Hewitt, Inc. (M.K.), Cincinnati, Ohio 45219;
- S. A. M. Clinical Research Center (S.M.), San Antonio, Texas 78229;
- Downtown Women's Health Care (US)
- Clinique RSF, Inc. (C.B.), Quebec, Canada G1S 2L6;
- St. Michael's Hospital (CA)
- Procter & Gamble (United States) (US)
- Jean Hailes (AU)
- Corresponding author
- Simon, James
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-09-01
- Volume
- 90
- Issue
- 9
- Pages
- 5226-5233
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2041293595
- Semantic Scholar
- 26f1f458c86409345ab57bb45f0ed0c5705b02c2
- Cited by
- 475
- References
- 17
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 6 · 2023: 8 · 2022: 15 · 2021: 23 · 2020: 20 · 2019: 13 · 2018: 22 · 2017: 25 · 2016: 18 · 2015: 13 · 2014: 17 · 2013: 19 · 2012: 35
- FWCI
- 24.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- testosterone patch, hypoactive sexual desire disorder, surgical menopause, sexual desire, sexual activity, sexual dysfunction, salpingo-oophorectomy, estrogen therapy, testosterone replacement therapy, treatment safety
- MeSH terms
- Administration, Cutaneous, Androgens, Double-Blind Method, Female, Humans, Libido, Menopause, Premature, Sexual Behavior, Gynecologic Surgical Procedures, Testosterone, Treatment Outcome, Sexual Dysfunctions, Psychological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.